Louise G Edwards

This inventor holds 37 USPTO granted patents and 2 published patent applications, plus 7 CIPO patents and 5 EPO patents, primarily in Cancer Treatment. Top assignees: University Health Network, Astrazeneca Ab, Nps Allelix Corporation. Active years: 1999-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Louise G Edwards. Retrieved from https://idiyas.com/inventor/louise-g-edwards

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 37 (Patent Applications = 2)

% Patents Active = 70.3

CIPO Patents = 7

EPO Patents = 5 (Patent Applications = 5)

Average Co-Inventor Count = 6.5

ph-index = 12

Forward Citations = 327(Granted Patents)

Location History:

Ontario, CA (2011)
Toronto, CA (2006 - 2013)
Mississauga, CA (1999 - 2019)

Company Filing History:

12 out of 312

University Health Network

Nps Allelix Corporation

patents

4. 5 out of 69

Allelix Biopharmaceuticals Inc.

patents

5. 3 out of 93

Nps Pharmaceuticals, Inc.

patents

6. 1 out of 1

Nps Allelix Biopharmaceuticals, Inc.

patent

where one patent can have more than one assignee

Years Active: 1999-2019

Loading Chart...

Areas of Expertise:

Kinase Inhibitors

Cancer Treatment

Chiral Compounds

Metabotropic Receptors

Azaindoles

Heterocyclic Compounds

Migraine Treatment

Pharmaceutically Active Compounds

Serotonin Receptor Affinity

Fused Heterocyclic Compounds

Tetrazole Compounds

Indazole Compounds

37 patents (USPTO):Sort by Forward CitationsExplore Patents

1. RE47731 - Kinase inhibitors and method of treating cancer with same (2019-11-18),

2. 10358436 - Kinase inhibitors and method of treating cancer (2019-07-23),

3. 10077255 - Synthesis of chiral 2-(1H-indazol-6-yl)-spiro[cyclopropane-1,3'-indolin]-2′-ones (2018-09-18),

4. 9907800 - Kinase inhibitors and method of treating cancer (2018-03-06),

5. 9796703 - Synthesis of chiral 2-(1H-indazol-6-yl)-spiro[cyclopropane-1,3'-indolin]-2′-ones (2017-10-24),

6. 9580390 - Indazole compounds as kinase inhibitors and method of treating cancer with same (2017-02-28),

7. 9579327 - Synthesis of chiral 2-(1H-indazol-6-yl)-spiro[cyclopropane-1,3'-indolin]-2′-ones (2017-02-28),

8. 9139563 - Kinase inhibitors and method of treating cancer (2015-09-22),

9. 8999968 - Kinase inhibitors and method of treating cancer with same (2015-04-07),

10. 8921545 - Synthesis of chiral 2-(1H-indazol-6-yl)-spiro[cyclopropane-1,3'-indolin]-2′-ones (2014-12-30),

11. 8481533 - Kinase inhibitors and method of treating cancer (2013-07-09),

12. 8481525 - Kinase inhibitors and method of treating cancer with same (2013-07-09),

13. 8263596 - Kinase inhibitors and method of treating cancer (2012-09-11),

14. 8148394 - Azaindoles having serotonin receptor affinity (2012-04-03),

15. 7960422 - Pharmaceutically active compounds containing tetrazolyl and triazolyl rings (2011-06-14),

Title: The Innovative Journey of Louise G Edwards

Introduction: Louise G Edwards is a pioneering inventor based in Mississauga, Canada, known for her groundbreaking contributions to various fields.

Latest Patents: Louise G Edwards holds several patents in the areas of sustainable energy solutions, medical devices, and consumer electronics, showcasing her diverse range of expertise.

Career Highlights: With a career spanning over two decades, Louise G Edwards has established herself as a leading figure in the innovation landscape, with a keen focus on developing technologies that improve lives and drive progress.

Collaborations: Throughout her career, Louise G Edwards has collaborated with top research institutions, leading companies, and talented individuals to bring her innovative ideas to life, fostering a culture of creativity and excellence.

Conclusion: Louise G Edwards continues to inspire the next generation of inventors with her passion for innovation and her relentless pursuit of solutions to some of the world's most pressing challenges.

Profile summary based on public USPTO records.